发明授权
US07157577B2 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
失效
5-磺酰氨基取代的吲哚啉酮化合物作为蛋白激酶抑制剂
- 专利标题： 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
- 专利标题（中）： 5-磺酰氨基取代的吲哚啉酮化合物作为蛋白激酶抑制剂
-
申请号： US10793952申请日： 2004-03-08
-
公开(公告)号： US07157577B2公开(公告)日： 2007-01-02
- 发明人: Peng Cho Tang , Congxin Liang , Todd Miller , Kenneth E. Lipson
- 申请人： Peng Cho Tang , Congxin Liang , Todd Miller , Kenneth E. Lipson
- 申请人地址： US CA South San Francisco
- 专利权人： Sugen Inc.
- 当前专利权人： Sugen Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理商 Bryan C. Zielinski; Vincent P. Liptak
- 主分类号： C07D413/14
- IPC分类号： C07D413/14 ; C07D403/14 ; C07D403/06
摘要：
The present invention relates to 5-sulfonamido substituted indolinones that modulate the activity of protein kinases (“PKs”). The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
公开/授权文献
信息查询
